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minute, and without AV block were enrolled and followed in effort
to identify the proportion diagnosed with SND and subsequently
treated. Rationale for not receiving pacemaker therapy for SND
was recorded. A multivariable logistic regression assessed the
association between baseline characteristics and probability of
receiving an implant after SND diagnosis.
Results: Patients (n = 510) enrolled from India and Bangladeshwere
more likely to be male (78%), with a mean age of 58  15 years, and
a history of Sinus brady/SND (63%) at baseline. Through 8.4  8.0
months follow-up, 369 received an SND diagnosis and 61 (17%) of
patients were implanted with a pacemaker. Insurance-related
issues (34%), physician preference for other medical management
(23%), patient not agreeing that their condition warranted implant
(22%), and physician determining patient was not indicated (19%)
were the dominant reasons for declining a pacemaker. Higher age,
female gender, and syncopal or pre-syncopal symptoms 30 days
prior to baseline visit were associated with a higher probability of
implant (Table 1).
Conclusions: In a real-world assessment in South Asia, 1 in 6
patients diagnosed with symptomatic SND receive a permanent
cardiac pacemaker with less than half of declines being related to
insurance reasons. Younger males were the least likely to receive
therapy. A process improvement initiative is warranted to improve
the diagnosis and therapy application.
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Introduction: The prevalence of ventriculoatrial (VA) conduction
varies from nearly 20% to 90%, depending on the population
studied. This ﬁgure is based on small studies done for different
arrhythmias. However, the prevalence of VA conduction in struc-
turally normal hearts has not been well documented to the best of
our knowledge.
Methods: Data was recorded in 47 consecutive adults without
structural heart disease, undergoing electrophysiological study
and ablation for tachyarrhythmias. AV nodal re-entrant tachycar-
dia was excluded. All procedures were performed under local
anesthesia in an anti-arrhythmic drug free state. The measure-
ments for this study were performed after ablation. The PR, QRS,
AH and HV intervals, atrioventricular Wenckebach point (AVWP)
and anterograde effective refractory period of atrioventricular
node (AVNERP) were measured. VA conduction was assessed; if
absent, it was retested after isoprenaline. VA Wenckebach point
(VAWP) and retrograde effective refractory period (VAERP) were
recorded in patients showing VA conduction. Age, gender, PR, AH,
HV, AVNERP and AVWP were assessed as correlates/predictors of
VA conduction. One-sided Fisher's exact test and unpaired t test
were used as necessary.
Results: The age of the patients was 37  13 years. Twenty-one
(45%) patients weremen and 26 (55%) were women. VA conduction
was present in 26 (55%) patients at baseline. Of the remaining 21
patients, 16 patients showed VA conduction after isoprenaline.
Only 5 (11%) patients failed to reveal VA conduction even after
isoprenaline. Of the variables studied, only the HV interval was
signiﬁcantly different (36.6  10.6 vs 49.2  5.8 ms, p < 0.003) in
patients with VA conduction. All parameters of patients with
baseline VA conduction and those with VA conduction only after
isoprenaline were similar, except the QRS duration which was
signiﬁcantly higher in patients with baseline VA conduction (90
 20.9 vs 80.1  8.4 ms, p < 0.05).
Conclusions: VA conduction is present in 55% of people with
structurally normal hearts. Isoprenaline enables VA conduction
in another 34% of these subjects. Age, gender and indicators of
AV conduction such as PR interval, AH, AVNERP and AVWP do
not differ whether VA conduction is present or absent. The
HV interval is longer in patients without VA conduction.
The QRS duration is more in patients with VA conduction at
baseline as compared to those with VA conduction only after
isoprenaline.





 10% of ventricular arrhythmias occurs in structurally normal
heart
 Classiﬁed into three groups:
 Outﬂow tract ventricular arrhythmia
 Idiopathic left ventricular tachycardia (ILVT)
 Automatic ventricular tachycardia
Outﬂow tract arrhythmia – Our experience 2011–2013
 Total OT-VA cases: 18
 Male:Female: 6:12
 Age: 22–63 years
 Co morbidity: HTN 6 cases
 Symptoms: Palpitation and giddiness
 ECG in SR: Normal in 15 and incomplete RBBB in 3
 ECG in VA: LBBB morphology and inferior axis and transition at
V4 – RVOT
 Clinical presentation: sustained VT-7 and PVC's and
NSVT-11
 Holter: PVC's ranges from 16,600 to 59,000/24 h (15–50%)
 Echo: LV dysfunction-5 (2 old MI)
 MRI with contrast: 6 patients – 2 ARVC
Mapping system:
 CARTO 3 system-8
 Ensite Array balloon-5
 Ensite velocity-4 and 2D-1
Table 1 – Multi-variable analysis of factors affecting
pacemaker implant probability.
Parameter OR (95% CI) p-Value
Age (per year) 1.03 (1.01, 1.06) 0.005
Female gender 2.41 (1.21, 4.79) 0.01
Contributes ﬁnancially
to household
0.58 (0.29, 1.14) 0.11
Syncope/presyncopal
symptoms 30 days prior
to baseline visit
4.35 (2.26, 8.35) <0.0001
Education (vs none formal)
Primary 0.96 (0.32, 2.86) 0.27
Secondary/High School 1.65 (0.54, 5.09) 0.38
College/Graduate 1.78 (0.59, 5.38) 0.23
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